Amarantus Bioscience Holdings Inc (AMBS)

[PENNYS ToMILLIONS]

As we further carve-out our position as the partner of choice for any MANF-based product development effort, we expect that we will be successful in attracting the necessary financial commitments to move MANF into clinical testing based upon the success of experiments already underway. As we continue to show progress in Parkinson’s disease, we will likely be in a good negotiating position with potential partners seeking to commercialize MANF both in Parkinson’s and other medical conditions, which could create multiple partnering opportunities for the Company.